Christopher P. Molineaux

Insider Reports History

Location
Wayne, PA
Signature
/s/ Matthew Rothman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher P. Molineaux:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aclaris Therapeutics, Inc. Director Common Stock 57,956 $88,672 $1.53 06 Jun 2025 Direct
Aclaris Therapeutics, Inc. Director Restricted Stock Units 0 $4,937 $1.03 06 Jun 2025 Direct
Aclaris Therapeutics, Inc. Director Stock Option (Right to Buy) 42,350 05 Jun 2025 Direct

Insider Reports Filed by Christopher P. Molineaux

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACRS Aclaris Therapeutics, Inc. 05 Jun 2025 4 $0 4 Director 09 Jun 2025, 16:20
ACRS Aclaris Therapeutics, Inc. 06 Jun 2024 2 $0 4 Director 10 Jun 2024, 16:15
ACRS Aclaris Therapeutics, Inc. 01 Jun 2024 2 $0 4 Director 04 Jun 2024, 16:30
ACRS Aclaris Therapeutics, Inc. 20 Jun 2023 2 +$23,265 4 Director 22 Jun 2023, 16:32
ACRS Aclaris Therapeutics, Inc. 15 Jun 2023 4 +$338 4 Director 20 Jun 2023, 16:31
ACRS Aclaris Therapeutics, Inc. 01 Jun 2023 4 $0 4 Director 05 Jun 2023, 17:02
ACRS Aclaris Therapeutics, Inc. 02 Jun 2022 4 $0 4 Director 06 Jun 2022, 17:27
ACRS Aclaris Therapeutics, Inc. 03 Jun 2021 2 $0 4 Director 04 Jun 2021, 20:05